AAAAAA

   
Results: 1-25 |
Results: 25
Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct
Authors: Tascilar, M Offerhaus, GJA Altink, R Argani, P Sohn, TA Yeo, CJ Cameron, JL Goggins, M Hruban, RH Wilentz, RE
Citation: M. Tascilar et al., Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct, AM J CLIN P, 116(6), 2001, pp. 831-837
Renal cell carcinoma metastatic to the pancreas: Results of surgical management
Authors: Sohn, TA Yeo, CJ Cameron, JL Nakeeb, A Lillemoe, KD
Citation: Ta. Sohn et al., Renal cell carcinoma metastatic to the pancreas: Results of surgical management, J GASTRO S, 5(4), 2001, pp. 346-351
Differing rates of loss of Dpc4 expression and of p53 overexpression amongcarcinomas of the proximal and distal bile ducts - Evidence for biologic distinction
Authors: Argani, P Shaukat, A Kaushal, M Wilentz, RE Su, GH Sohn, TA Yeo, GJ Cameron, JL Kern, SE Hruban, RH
Citation: P. Argani et al., Differing rates of loss of Dpc4 expression and of p53 overexpression amongcarcinomas of the proximal and distal bile ducts - Evidence for biologic distinction, CANCER, 91(7), 2001, pp. 1332-1341
Intraductal papillary mucinous neoplasms of the pancreas: An increasingly recognized clinicopathologic entity
Authors: Sohn, TA Yeo, CJ Cameron, JL Iacobuzio-Donahue, CA Hruban, RH Lillemoe, KD
Citation: Ta. Sohn et al., Intraductal papillary mucinous neoplasms of the pancreas: An increasingly recognized clinicopathologic entity, ANN SURG, 234(3), 2001, pp. 313-321
Intraductal papillary mucinous neoplasms of the pancreas: An increasingly recognized clinicopathologic entity - Discussion
Authors: Warshaw, AL Traverso, LW Ellison, EC Sohn, TA Way, LW
Citation: Al. Warshaw et al., Intraductal papillary mucinous neoplasms of the pancreas: An increasingly recognized clinicopathologic entity - Discussion, ANN SURG, 234(3), 2001, pp. 321-322
High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells
Authors: Sohn, TA Su, GH Ryu, B Yeo, CJ Kern, SE
Citation: Ta. Sohn et al., High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells, ANN SURG, 233(5), 2001, pp. 696-702
High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells - Discussion
Authors: Evers, BM Urist, MM Sohn, TA
Citation: Bm. Evers et al., High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells - Discussion, ANN SURG, 233(5), 2001, pp. 702-703
Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid
Authors: Udelsman, R Westra, WH Donovan, PI Sohn, TA Cameron, JL
Citation: R. Udelsman et al., Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid, ANN SURG, 233(5), 2001, pp. 716-721
Resected adenocarcinoma of the pancreas - 616 patients: Results, outcomes,and prognostic indicators
Authors: Sohn, TA Yeo, CJ Cameron, JL Koniaris, L Kaushal, S Abrams, RA Sauter, PK Coleman, J Hruban, RH Lillemoe, KD
Citation: Ta. Sohn et al., Resected adenocarcinoma of the pancreas - 616 patients: Results, outcomes,and prognostic indicators, J GASTRO S, 4(6), 2000, pp. 567-579
Quality of life and long-term survival after surgery for chronic pancreatitis
Authors: Sohn, TA Campbell, KA Pitt, HA Sauter, PK Coleman, J Lillemoe, KD Yeo, CJ Cameron, JL
Citation: Ta. Sohn et al., Quality of life and long-term survival after surgery for chronic pancreatitis, J GASTRO S, 4(4), 2000, pp. 355-364
Do preoperative biliary stents increase postpancreaticoduodenectomy complications?
Authors: Sohn, TA Yeo, CJ Cameron, JL Pitt, HA Lillemoe, KD
Citation: Ta. Sohn et al., Do preoperative biliary stents increase postpancreaticoduodenectomy complications?, J GASTRO S, 4(3), 2000, pp. 258-267
The molecular genetics of pancreatic ductal carcinoma: a review
Authors: Sohn, TA Yeo, CJ
Citation: Ta. Sohn et Cj. Yeo, The molecular genetics of pancreatic ductal carcinoma: a review, SURG ONCOL, 9(3), 2000, pp. 95-101
A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library
Authors: Su, GH Sohn, TA Ryu, B Kern, SE
Citation: Gh. Su et al., A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library, CANCER RES, 60(12), 2000, pp. 3137-3142
Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospectiverandomized placebo-controlled trial
Authors: Yeo, CJ Cameron, JL Lillemoe, KD Sauter, PK Coleman, J Sohn, TA Campbell, KA Choti, MA
Citation: Cj. Yeo et al., Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospectiverandomized placebo-controlled trial, ANN SURG, 232(3), 2000, pp. 419-426
Quality of life and outcomes after pancreaticoduodenectomy
Authors: Huang, JJ Yeo, CJ Sohn, TA Lillemoe, KD Sauter, PK Coleman, J Hruban, RH Cameron, JL
Citation: Jj. Huang et al., Quality of life and outcomes after pancreaticoduodenectomy, ANN SURG, 231(6), 2000, pp. 890-896
Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas - Comparison with conventional ductal adenocarcinomas
Authors: Iacobuzio-Donahue, CA Klimstra, DS Adsay, NV Wilentz, RE Argani, P Sohn, TA Yeo, CJ Cameron, JL Kern, SE Hruban, RH
Citation: Ca. Iacobuzio-donahue et al., Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas - Comparison with conventional ductal adenocarcinomas, AM J PATH, 157(3), 2000, pp. 755-761
Genetic, immunohistochemical, and clinical features of medullary carcinomaof the pancreas - A newly described and characterized entity
Authors: Wilentz, RE Goggins, M Redston, M Marcus, VA Adsay, NV Sohn, TA Kadkol, SS Yeo, CJ Choti, M Zahurak, M Johnson, K Tascilar, M Offerhaus, GJA Hruban, RH Kern, SE
Citation: Re. Wilentz et al., Genetic, immunohistochemical, and clinical features of medullary carcinomaof the pancreas - A newly described and characterized entity, AM J PATH, 156(5), 2000, pp. 1641-1651
Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreaticadenocarcinomas - A new marker of DPC4 inactivation
Authors: Wilentz, RE Su, GH Le Dai, J Sparks, AB Argani, P Sohn, TA Yeo, CJ Kern, SE Hruban, RH
Citation: Re. Wilentz et al., Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreaticadenocarcinomas - A new marker of DPC4 inactivation, AM J PATH, 156(1), 2000, pp. 37-43
Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s
Authors: Sohn, TA Lillemoe, KD Cameron, JL Huang, JJ Pitt, HA Yeo, CJ
Citation: Ta. Sohn et al., Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s, J AM COLL S, 188(6), 1999, pp. 658-666
Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: Survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels
Authors: Abrams, RA Grochow, LB Chakravarthy, A Sohn, TA Zahurak, ML Haulk, TL Ord, S Hruban, RH Lillemoe, KD Pitt, HA Cameron, JL Yeo, CJ
Citation: Ra. Abrams et al., Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: Survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels, INT J RAD O, 44(5), 1999, pp. 1039-1046
Untitled - Reply
Authors: Yeo, CJ Sohn, TA Lillemoe, KD Cameron, JL
Citation: Cj. Yeo et al., Untitled - Reply, ANN SURG, 230(5), 1999, pp. 736-737
Is prophylactic gastrojejunostomy indicated for unresectable periampullarycancer? A prospective randomized trial
Authors: Lillemoe, KD Cameron, JL Hardacre, JM Sohn, TA Sauter, PK Coleman, J Pitt, HA Yeo, CJ
Citation: Kd. Lillemoe et al., Is prophylactic gastrojejunostomy indicated for unresectable periampullarycancer? A prospective randomized trial, ANN SURG, 230(3), 1999, pp. 322-328
Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma - Comparison of morbidity and mortality and short-term outcome
Authors: Yeo, CJ Cameron, JL Sohn, TA Coleman, J Sauter, PK Hruban, RH Pitt, HA Lillemoe, KD
Citation: Cj. Yeo et al., Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma - Comparison of morbidity and mortality and short-term outcome, ANN SURG, 229(5), 1999, pp. 613-624
Distal pancreatectomy: Indications and outcomes in 235 patients
Authors: Lillemoe, KD Kaushal, S Cameron, JL Sohn, TA Pitt, HA Yeo, CJ
Citation: Kd. Lillemoe et al., Distal pancreatectomy: Indications and outcomes in 235 patients, ANN SURG, 229(5), 1999, pp. 693-700
Reexploration for periampullary carcinoma - Resectability, perioperative results, pathology, and long-term outcome
Authors: Sohn, TA Lillemoe, KD Cameron, JL Pitt, HA Huang, JJ Hruban, RH Yeo, CJ
Citation: Ta. Sohn et al., Reexploration for periampullary carcinoma - Resectability, perioperative results, pathology, and long-term outcome, ANN SURG, 229(3), 1999, pp. 393-400
Risultati: 1-25 |